Locations and molecular forms of gastrin-releasing peptide-like immunoreactive entities in ovine pregnancy. 1996

Q Xiao, and J R Challis, and M Fraser, and M E Wlodek, and G D Thorburn, and F Cuttita, and D J Hill, and S St-Pierre, and E R Spindel, and T J McDonald
Department of Medicine, University of Western Ontario, London, Canada.

Large quantities of gastrin-releasing peptide-like immunoreactivity (GRP-LI) are present in ovine pregnancy fluids (allantoic fluid > fetal plasma > esophageal fluid = amniotic fluid = urine > maternal plasma) and in term endometrium (60 +/- 29 pmol.g-1) and myometrium (4.5 +/- 1.2 pmol.g-1). The larger molecular size [greater than GRP (1-27)] of this GRP-LI entity is not due to a GRP binding protein nor to a C-terminal extension of GRP. In contrast, ovine fetal colon extracts appear to contain the usual GRP (1-27) and GRP (18-27) forms. Hence, the uterus, not the fetus, is the probable source of this novel GRP-like peptide. It apparently acts as a hormone in ovine pregnancy and may play an important role in fetal-placental development.

UI MeSH Term Description Entries
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D010455 Peptides Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS. Peptide,Polypeptide,Polypeptides
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011270 Pregnancy, Animal The process of bearing developing young (EMBRYOS or FETUSES) in utero in non-human mammals, beginning from FERTILIZATION to BIRTH. Animal Pregnancies,Animal Pregnancy,Pregnancies, Animal
D011863 Radioimmunoassay Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation. Radioimmunoassays
D001826 Body Fluids Liquid components of living organisms. Body Fluid,Fluid, Body,Fluids, Body
D003429 Cross Reactions Serological reactions in which an antiserum against one antigen reacts with a non-identical but closely related antigen. Cross Reaction,Reaction, Cross,Reactions, Cross
D005260 Female Females
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

Q Xiao, and J R Challis, and M Fraser, and M E Wlodek, and G D Thorburn, and F Cuttita, and D J Hill, and S St-Pierre, and E R Spindel, and T J McDonald
October 1991, Biochemical and biophysical research communications,
Q Xiao, and J R Challis, and M Fraser, and M E Wlodek, and G D Thorburn, and F Cuttita, and D J Hill, and S St-Pierre, and E R Spindel, and T J McDonald
January 1984, Histochemistry,
Q Xiao, and J R Challis, and M Fraser, and M E Wlodek, and G D Thorburn, and F Cuttita, and D J Hill, and S St-Pierre, and E R Spindel, and T J McDonald
October 1990, The Journal of clinical endocrinology and metabolism,
Q Xiao, and J R Challis, and M Fraser, and M E Wlodek, and G D Thorburn, and F Cuttita, and D J Hill, and S St-Pierre, and E R Spindel, and T J McDonald
April 1991, Biochemical and biophysical research communications,
Q Xiao, and J R Challis, and M Fraser, and M E Wlodek, and G D Thorburn, and F Cuttita, and D J Hill, and S St-Pierre, and E R Spindel, and T J McDonald
March 1993, The European respiratory journal,
Q Xiao, and J R Challis, and M Fraser, and M E Wlodek, and G D Thorburn, and F Cuttita, and D J Hill, and S St-Pierre, and E R Spindel, and T J McDonald
January 2009, BioFactors (Oxford, England),
Q Xiao, and J R Challis, and M Fraser, and M E Wlodek, and G D Thorburn, and F Cuttita, and D J Hill, and S St-Pierre, and E R Spindel, and T J McDonald
June 2002, Molecular pharmacology,
Q Xiao, and J R Challis, and M Fraser, and M E Wlodek, and G D Thorburn, and F Cuttita, and D J Hill, and S St-Pierre, and E R Spindel, and T J McDonald
December 1994, Endocrinology,
Q Xiao, and J R Challis, and M Fraser, and M E Wlodek, and G D Thorburn, and F Cuttita, and D J Hill, and S St-Pierre, and E R Spindel, and T J McDonald
December 1994, Endocrinology,
Q Xiao, and J R Challis, and M Fraser, and M E Wlodek, and G D Thorburn, and F Cuttita, and D J Hill, and S St-Pierre, and E R Spindel, and T J McDonald
February 1994, Neuropeptides,
Copied contents to your clipboard!